Literature DB >> 8406658

Renal responses to intra-arterial administration of nitric oxide donor in dogs.

D S Majid1, A Williams, P J Kadowitz, L G Navar.   

Abstract

Inhibition of nitric oxide synthesis by intra-arterial administration of nitro-L-arginine (NLA) leads to attenuation of the slope of the relation between renal arterial pressure (RAP) and sodium excretion without an alteration in renal autoregulatory efficiency. In the present study, we examined whether only the presence of nitric oxide or, alternatively, changes in nitric oxide production during changes in RAP are required for pressure natriuresis to occur. Anesthetized sodium-replete dogs (n = 8) were treated with NLA (50 micrograms.kg-1 x min-1) to inhibit endogenous nitric oxide formation, and S-nitroso-n-acetylpenicillamine (SNAP) was infused intra-arterially at a constant rate (2 micrograms.kg-1 x min-1) to replenish intrarenal nitric oxide levels. Renal responses to reductions in RAP within the autoregulatory range were assessed before and during NLA infusion followed by SNAP+NLA infusion. As reported previously, NLA infusion alone increased renal vascular resistance and decreased renal blood flow, urine flow, sodium excretion, and fractional excretion of sodium, with no change in glomerular filtration rate. Autoregulatory efficiency remained intact, whereas the pressure-induced natriuretic responses were attenuated. During SNAP+NLA infusion, renal blood flow increased from 2.8 +/- 0.3 to 3.5 +/- 0.3 mL.min-1 x g-1 (P < .001), without significant changes in glomerular filtration rate (0.75 +/- 0.07 to 0.81 +/- 0.05 mL.min-1 x g-1); the autoregulatory efficiency of renal blood flow and glomerular filtration rate remained intact. SNAP increased urine flow (4.8 +/- 1.8 to 10.0 +/- 2.5 microL.min-1 x g-1), sodium excretion (0.63 +/- 0.26 to 1.70 +/- 0.37 mumol.min-1 x g-1), and fractional excretion of sodium (0.55 +/- 0.20% to 1.38 +/- 0.27%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406658     DOI: 10.1161/01.hyp.22.4.535

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  Regulatory roles of nitric oxide and angiotensin II on renal tubular transport.

Authors:  Shoko Horita; Motonobu Nakamura; Ayumi Shirai; Osamu Yamazaki; Nobuhiko Satoh; Masashi Suzuki; George Seki
Journal:  World J Nephrol       Date:  2014-11-06

3.  Role of shear stress in nitric oxide-dependent modulation of renal angiotensin II vasoconstriction.

Authors:  K Endlich; C Muller; M Barthelmebs; J J Helwig
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

4.  Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice.

Authors:  Mohd Shahid; Joseph Francis; Khalid Matrougui; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-21

5.  Nitric oxide inhibits arginine-vasotocin-induced increase of water osmotic permeability in frog urinary bladder.

Authors:  Ekaterina M Fock; Elena A Lavrova; Vera T Bachteeva; Elena V Chernigovskaya; Rimma G Parnova
Journal:  Pflugers Arch       Date:  2004-01-14       Impact factor: 3.657

6.  Angiotensin II-mediated hypertension impairs nitric oxide-induced NKCC2 inhibition in thick ascending limbs.

Authors:  Vanesa D Ramseyer; Pablo A Ortiz; Oscar A Carretero; Jeffrey L Garvin
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-17

Review 7.  Epithelial transport during septic acute kidney injury.

Authors:  Eric D Morrell; John A Kellum; Kenneth R Hallows; Núria M Pastor-Soler
Journal:  Nephrol Dial Transplant       Date:  2013-12-29       Impact factor: 5.992

8.  Modulation of the myogenic mechanism: concordant effects of NO synthesis inhibition and O2- dismutation on renal autoregulation in the time and frequency domains.

Authors:  Nicholas G Moss; Tayler K Gentle; William J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-28

9.  Chronic resveratrol reverses a mild angiotensin II-induced pressor effect in a rat model.

Authors:  Kevin L Gordish; William H Beierwaltes
Journal:  Integr Blood Press Control       Date:  2016-01-28

10.  Sustained resveratrol infusion increases natriuresis independent of renal vasodilation.

Authors:  Kevin L Gordish; William H Beierwaltes
Journal:  Physiol Rep       Date:  2014-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.